Jury is out over HRT heart risks
More research is needed over the safety of hormone replacement therapy, says an expert.
Johnson &amp; Johnson will delay by five months the release of a study comparing its Cypher heart device with Boston Scientific Corp.'s Taxus, the first large-scale comparison of the only two drug-coated stents on the market.